Citigroup Inc Catalyst Pharmaceuticals, Inc. Transaction History

Citigroup Inc

$153 Billion
Q2 2024

A detailed history of Citigroup Inc transactions in Catalyst Pharmaceuticals, Inc. stock. As of the latest transaction made, Citigroup Inc holds 115,111 shares of CPRX stock, worth $2.25 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

115,111

Previous 490,704 76.54%

Holding current value

$2.25 Million

Previous $7.82 Million 77.2%

% of portfolio

0.0%

Previous 0.01%

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 12, 2024	SELL	$14.68 - $16.92 $5.51 Million - $6.36 Million	-375,593 Reduced 76.54%	115,111 $1.78 Million
Q1 2024 May 10, 2024	BUY	$13.18 - $17.11 $3.75 Million - $4.87 Million	284,860 Added 138.39%	490,704 $7.82 Million
Q4 2023 Feb 09, 2024	SELL	$11.78 - $17.29 $618,237 - $907,413	-52,482 Reduced 20.32%	205,844 $3.46 Million
Q3 2023 Nov 09, 2023	SELL	$11.69 - $15.02 $328,266 - $421,776	-28,081 Reduced 9.8%	258,326 $3.02 Million
Q2 2023 Aug 10, 2023	SELL	$11.5 - $18.08 $1.68 Million - $2.64 Million	-145,897 Reduced 33.75%	286,407 $3.85 Million
Q1 2023 May 11, 2023	BUY	$14.34 - $21.05 $2.05 Million - $3.01 Million	143,137 Added 49.5%	432,304 $7.17 Million
Q4 2022 Feb 09, 2023	SELL	$12.25 - $19.5 $1.66 Million - $2.64 Million	-135,470 Reduced 31.9%	289,167 $5.38 Million
Q3 2022 Nov 10, 2022	BUY	$7.06 - $15.52 $1.53 Million - $3.36 Million	216,408 Added 103.93%	424,637 $5.45 Million
Q2 2022 Aug 10, 2022	BUY	$6.23 - $8.57 $930,151 - $1.28 Million	149,302 Added 253.37%	208,229 $1.46 Million
Q1 2022 May 12, 2022	SELL	$5.31 - $8.31 $811,941 - $1.27 Million	-152,908 Reduced 72.18%	58,927 $489,000
Q4 2021 Feb 10, 2022	BUY	$5.21 - $7.45 $414,398 - $592,565	79,539 Added 60.12%	211,835 $1.43 Million
Q3 2021 Nov 10, 2021	BUY	$4.85 - $6.04 $641,635 - $799,067	132,296 New	132,296 $701,000

Others Institutions Holding CPRX

# of Institutions

285

Shares Held

96.6M

Call Options Held

29.2K

Put Options Held

20.5K

View Full List

About CATALYST PHARMACEUTICALS, INC.

Ticker CPRX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 102,820,000
Market Cap $2.01B
Description
Catalyst Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on developing and commercializing therapies for people with rare debilitating, chronic neuromuscular, and neurological diseases in the United States. It offers Firdapse, an amifampridine phosphate tablets for the treatment of patients with lambert-eaton myasthe...

More about CPRX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Citigroup Inc, based on Form 13F filings with the SEC.

News

Stay updated on Citigroup Inc with notifications on news.

Account